OIL Stock Overview
Engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, and Internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Optiscan Imaging Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.12 |
52 Week High | AU$0.14 |
52 Week Low | AU$0.071 |
Beta | 1.5 |
1 Month Change | 44.58% |
3 Month Change | 33.33% |
1 Year Change | 41.18% |
3 Year Change | -61.29% |
5 Year Change | 155.32% |
Change since IPO | -40.00% |
Recent News & Updates
Recent updates
We're Keeping An Eye On Optiscan Imaging's (ASX:OIL) Cash Burn Rate
Jan 16We're Keeping An Eye On Optiscan Imaging's (ASX:OIL) Cash Burn Rate
Sep 19We're Not Very Worried About Optiscan Imaging's (ASX:OIL) Cash Burn Rate
Jun 10Optiscan Imaging (ASX:OIL) Is In A Strong Position To Grow Its Business
Dec 30We're Not Worried About Optiscan Imaging's (ASX:OIL) Cash Burn
Aug 02How Much Of Optiscan Imaging Limited (ASX:OIL) Do Insiders Own?
Mar 04Can You Imagine How Jubilant Optiscan Imaging's (ASX:OIL) Shareholders Feel About Its 253% Share Price Gain?
Dec 02Shareholder Returns
OIL | AU Medical Equipment | AU Market | |
---|---|---|---|
7D | 14.3% | 0.2% | -0.3% |
1Y | 41.2% | 15.7% | 8.5% |
Return vs Industry: OIL exceeded the Australian Medical Equipment industry which returned 15.7% over the past year.
Return vs Market: OIL exceeded the Australian Market which returned 8.5% over the past year.
Price Volatility
OIL volatility | |
---|---|
OIL Average Weekly Movement | 13.0% |
Medical Equipment Industry Average Movement | 9.4% |
Market Average Movement | 8.8% |
10% most volatile stocks in AU Market | 17.0% |
10% least volatile stocks in AU Market | 3.3% |
Stable Share Price: OIL's share price has been volatile over the past 3 months.
Volatility Over Time: OIL's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | n/a | Camile Farah | www.optiscan.com |
Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, and Internationally. It offers InVivage, an intra-oral digital hand-held confocal endomicroscope for oral cancer screening and/or surgical margin determination; and ViewnVivo, a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging. The company has a collaboration agreement with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system for applications in robotic surgery.
Optiscan Imaging Limited Fundamentals Summary
OIL fundamental statistics | |
---|---|
Market cap | AU$100.24m |
Earnings (TTM) | -AU$5.44m |
Revenue (TTM) | AU$2.34m |
42.8x
P/S Ratio-18.4x
P/E RatioIs OIL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
OIL income statement (TTM) | |
---|---|
Revenue | AU$2.34m |
Cost of Revenue | AU$3.82m |
Gross Profit | -AU$1.48m |
Other Expenses | AU$3.96m |
Earnings | -AU$5.44m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0065 |
Gross Margin | -63.21% |
Net Profit Margin | -232.44% |
Debt/Equity Ratio | 1.1% |
How did OIL perform over the long term?
See historical performance and comparison